Literature DB >> 22424424

Biomarkers: hopes and challenges in the path from discovery to clinical practice.

Nikolaos G Frangogiannis1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22424424      PMCID： PMC4402218          DOI： 10.1016/j.trsl.2012.01.023

Source DB:  PubMed          Journal:  Transl Res        ISSN： 1878-1810            Impact factor:   7.012


× No keyword cloud information.
  46 in total

Review 1.  Biomarkers and surrogate endpoints: preferred definitions and conceptual framework.

Authors: 
Journal:  Clin Pharmacol Ther       Date:  2001-03       Impact factor: 6.875

2.  The interface between biomarker discovery and clinical validation: The tar pit of the protein biomarker pipeline.

Authors:  Amanda G Paulovich; Jeffrey R Whiteaker; Andrew N Hoofnagle; Pei Wang
Journal:  Proteomics Clin Appl       Date:  2008-10-01       Impact factor: 3.494

Review 3.  Protein biomarker discovery and validation: the long and uncertain path to clinical utility.

Authors:  Nader Rifai; Michael A Gillette; Steven A Carr
Journal:  Nat Biotechnol       Date:  2006-08       Impact factor: 54.908

4.  National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: Analytical issues for biochemical markers of acute coronary syndromes.

Authors:  Fred S Apple; Robert L Jesse; L Kristin Newby; Alan H B Wu; Robert H Christenson
Journal:  Circulation       Date:  2007-03-23       Impact factor: 29.690

5.  The thin line between hope and hype in biomarker research.

Authors:  Patrick M M Bossuyt
Journal:  JAMA       Date:  2011-06-01       Impact factor: 56.272

Review 6.  Marking renal injury: can we move beyond serum creatinine?

Authors:  Jessica L Slocum; Michael Heung; Subramaniam Pennathur
Journal:  Transl Res       Date:  2012-02-03       Impact factor: 7.012

Review 7.  The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function.

Authors:  Christopher B Cooper
Journal:  Am J Med       Date:  2006-10       Impact factor: 4.965

Review 8.  Diagnosis of myocardial infarction by serum isoenzyme analysis.

Authors:  C R Roe
Journal:  Ann Clin Lab Sci       Date:  1977 May-Jun       Impact factor: 1.256

Review 9.  State of the art: using natriuretic peptide levels in clinical practice.

Authors:  Alan Maisel; Christian Mueller; Kirkwood Adams; Stefan D Anker; Nadia Aspromonte; John G F Cleland; Alain Cohen-Solal; Ulf Dahlstrom; Anthony DeMaria; Salvatore Di Somma; Gerasimos S Filippatos; Gregg C Fonarow; Patrick Jourdain; Michel Komajda; Peter P Liu; Theresa McDonagh; Kenneth McDonald; Alexandre Mebazaa; Markku S Nieminen; W Frank Peacock; Marco Tubaro; Roberto Valle; Marc Vanderhyden; Clyde W Yancy; Faiez Zannad; Eugene Braunwald
Journal:  Eur J Heart Fail       Date:  2008-08-29       Impact factor: 15.534

10.  The prognostic value of monocyte chemoattractant protein-1/CCL2 in acute coronary syndromes.

Authors:  Nikolaos G Frangogiannis
Journal:  J Am Coll Cardiol       Date:  2007-11-13       Impact factor: 24.094
View more
  23 in total

Review 1.  The immune system and the remodeling infarcted heart: cell biological insights and therapeutic opportunities.

Authors:  Nikolaos G Frangogiannis
Journal:  J Cardiovasc Pharmacol       Date:  2014-03       Impact factor: 3.105

Review 2.  Fibroblasts in myocardial infarction: a role in inflammation and repair.

Authors:  Arti V Shinde; Nikolaos G Frangogiannis
Journal:  J Mol Cell Cardiol       Date:  2013-12-07       Impact factor: 5.000

Review 3.  Targeting inflammatory pathways in myocardial infarction.

Authors:  Panagiota Christia; Nikolaos G Frangogiannis
Journal:  Eur J Clin Invest       Date:  2013-06-17       Impact factor: 4.686

Review 4.  Fibroblasts in post-infarction inflammation and cardiac repair.

Authors:  Wei Chen; Nikolaos G Frangogiannis
Journal:  Biochim Biophys Acta       Date:  2012-09-07

Review 5.  Cancer biomarker discovery using DNA aptamers.

Authors:  Cheng Jin; Liping Qiu; Jin Li; Ting Fu; Xiaobing Zhang; Weihong Tan
Journal:  Analyst       Date:  2016-01-21       Impact factor: 4.616

Review 6.  Inflammation as a therapeutic target in myocardial infarction: learning from past failures to meet future challenges.

Authors:  Amit Saxena; Ilaria Russo; Nikolaos G Frangogiannis
Journal:  Transl Res       Date:  2015-07-17       Impact factor: 7.012

Review 7.  Obesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunities.

Authors:  Michele Cavalera; Junhong Wang; Nikolaos G Frangogiannis
Journal:  Transl Res       Date:  2014-05-10       Impact factor: 7.012

Review 8.  Targeting the chemokines in cardiac repair.

Authors:  Michele Cavalera; Nikolaos G Frangogiannis
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 9.  The extracellular matrix modulates fibroblast phenotype and function in the infarcted myocardium.

Authors:  Marcin Dobaczewski; Judith J de Haan; Nikolaos G Frangogiannis
Journal:  J Cardiovasc Transl Res       Date:  2012-09-07       Impact factor: 4.132

Review 10.  The inflammatory response in myocardial injury, repair, and remodelling.

Authors:  Nikolaos G Frangogiannis
Journal:  Nat Rev Cardiol       Date:  2014-03-25       Impact factor: 32.419
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.